ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Neuphoria Therapeutics Inc. (NEUP) stock surged +2.77%, trading at $5.20 on NASDAQ, up from the previous close of $5.06. The stock opened at $5.19, fluctuating between $5.10 and $5.22 in the recent session.
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.
Employees | 8 |
Beta | 0.26 |
Sales or Revenue | N/A |
5Y Sales Change% | -1% |
Fiscal Year Ends | N/A |
Sector | Healthcare |
Industry | Medical - Pharmaceuticals |